Understanding Generic vs Branded medicines under NMC

Medicines are generally discovered/invented by Pharma companies. The company which first discovers/invents the drug gets a patent (monopoly) to sell the drug for a fixed period of time (usually 15-20 yrs). This is referred to as the patented drug.
Once this period lapses, the patent expires & other companies can now make and sell this drug. These are called as generics..

For obvious reasons, the generics are cheaper than the patented drug, although the company making the patented drug does usually bring down the price of their brand when the patent expires, for obvious reasons (to compete with the generics).
Now it gets complicated. Any company wanting to market a generic drug does not have to do trials to show the drug is effective (which the original company with the patented drug had to do to get a licence).

However the generic companies do have to provide evidence that their drug is similar to the patented drug in all characteristics eg. Chemical content, it's bioavailability (meaning how the drug gets absorbed & is available in blood stream to act like the original patented drug).
Once they do this (called bioequivalence in technical terms), the generic drug gets a licence to be marketed. This licence is issued by the regulators eg FDA in US or EU in Europe etc. All these regulators insist on bioequivalence studies so that the generic drug will work as well as the patented drug.
Now the generic company has two options:

They can sell their generic drug with a brand name or just sell it with the approved chemical name.
The former are called branded generics and the latter are called just generics (I know, this is extremely confusing).

So what's the problem..?

The problem is the Indian regulators (unlike regulators in rest of the world) do not require bioequivalence studies to be done b4 companies get a licence to sell the drug.
So essentially we have no way of knowing whether the drug being marketed in India has the same quantity, quality, impurities etc when compared to the patented drug.

We have to just rely on the Indian Pharma company's word (with no data) that the generic drug they are selling is as good as the original patented drug.
Almost all the drugs sold in Indian market are generics bcoz very few global Pharma companies sell their patented meds here. Even when they do sell their patented medicines in India (once they go off patent) they sell them with a different brand name to their patented brand.

Now some Indian companies sell their generics with a brand name eg. Rozat (Rosurvastatin) sold by Dr Reddy's. Many of these companies also sell these same medicines abroad, so one is relying on the fact that if their drug is acceptable to global regulators, it must be of good quality. (It's an assumption but too complex to explain why here).
Anyways, you have some hope that companies like Cipla, Dr Reddy's, Sun etc have too much to lose by selling poor quality drugs in Indian market.

Then there are the generics. These are small companies (& there are thousands of them, it's a cottage industry) who sell the drug without a brand name & just the approved chemical name. They usually only sell in the local market. In most if not all instances their quality control is poor or non-existent. So a frequent problem with these drugs is NSQ (not sufficient quantity) meaning if a tablet says 200 mg it does not contain 200 mg. This is a real big problem bcoz you may take the medicine in the prescribed dose, but it does not work bcoz it does not have same quantity of drug.
Drs tend to write branded generics based on (a) trusting a reputed company (b) past experience with the brand quality etc. Detractors say that Drs prescribe a particular brand bcoz they get benefits from the Pharma company.

In response to this, the National Medical Commission says that Drs must only prescribe the approved generic name and not the branded generics.

You do see what the problem is here. It's the Indian regulators. They do not guarantee that the drugs they have licensed to be sold in Indian market are of good quality. Bcoz they do not require bioequivalence (remember that earlier in this thread?)

Basically you are taking a chance that the drug sold in India is of good quality.

When Drs are forced to write only the approved chemical name of the drug (not brand name), it is up to the chemist to give you medicine which may have been made by anyone -including a company based out of someone's garage or kitchen. You see it has not solved the problem - instead of pharma companies chasing Drs, they will now chase chemists to dispense their drugs.

Drs are atleast regulated by the NMC, chemists are not regulated by anyone. The chemist is likely to give you the drug made by a company which gives him the best commission & not necessarily the one that has any quality. That would be a business decision. In most instances, it will be a unbranded drug made by the cottage industry company.

Even when your Dr. writes a branded drug, there is a certain amount of guesswork about the quality of the drug bcoz the Indian regulators do not require bioequivalence to be proven.

The elephant in the room is actually the Indian regulators doing their job poorly. Why do they not insist on bioequivalence studies which is the best measure of quality for generic medicines is the Q we should be asking.
Of course we all want medicines to be cheap, but not at the cost of quality. After all your life is at stake.

If the Indian regulators only licensed medicines with bioequivalence data and studies, all Drs will have no problem prescribing medicines only by the generic approved name.

But until then, your best hope is to trust your Dr's judgement despite everything. more  

View all 9 comments Below 9 comments
It's very true in absolute terms. Well explained the pharma market scenario in domestic market. Common people are truly relying on Chemists and purchase medicines mostly generic as it keeps an option to have more margin. Usually in market we always used to listen, substitute is available and usually of poor quality & cheaper. Very few are really aware of contents that make it easy to push such products. In fact such medicines have a little impact. Your article will surely build an awareness among consumers. Wish, our Indian Regulator will also work on it seriously to stop marketing of such product with no quality evaluation report card. more  
Yes there us need to resurrect Indian drug and food regulators including State Health departments which are in shambles due to corruption, political patronage and non accountability. more  
A very well explained article. Thank you. However I have noticed, that a lot of Generic drugs have an MRP, cheaper than the patented medicine, but hardly any significant price difference. If you know a wholesaler, the drug is available at 40 % discount, but otherwise you are paying only a marginally lower price, than the patented one. So personally I would prefer to buy the original drug. As you rightly said, I would be sure of the quality and this effectiveness As the saying goes - "aachi cheej or sasti cheej mein farak hai". more  
I find that there is another problem as well. Many medicines which I take are combination drugs which contain more than one drug each with a particular dosage. If I have to take them as generic drugs, I will have to buy multiple drugs, each of the required dosage. I think that the government have not thought this through, nor they have taken into account the poor quality of generics, particularly, the unbranded generics that flood the market. Have they forgotten the recent cases where Indian cough syrups caused multiple deaths of African children? I think that the consumers will have to be cautious since the government is willing to play with the health of its citizens, instead of addressing the basic issue of poor quality drugs and ineffective drug regulation machinery. more  
Very well explained article and helpful to understand the ground reality. Now when our PM boasting of Jan Auoshadhalaya, does not he being briefed by our Health Minister about the prevailing lacuna and gap. I thank the PM at least made a start of generic medicine way, but lot needs to be done. Would request Local Circle Manager to take up the such important and pertinent issue with the ministry. more  
Post a Comment

Related Posts

    • Abolish Taxes because you aren’t delivering services to people

      If India abolishes taxes: (1) People would get money in hand to buy critical things like Air Purifiers (2) More foreign businesses would come. And, make India their base (this wil...

      By Ruchika L Maheshwari
      /
    • VIP culture rampant in India

      So glad that the LC manager has finally released the VIP culture survey. Saw in NBT yesterday and today in english media.

      By Amit Mishra
      /
    • Compromising Information of Children

      After Aadhaar, now it is ANOTHER 12-digit unique ID for school kids called APAAR ID which the Education Ministry has launched! Parents are being asked to give “consent” so that their ch...

      By Ruchika L Maheshwari
      /
    • We Indians are losing out

      The Indian rupee has lost approximately 42% of its value since 2014. In ten years, the value of your ₹100 has become roughly ₹58. ⚠️ - Are you analysing what's going on with your sa...

      By Mukul Puri
      /
    • Inflation impact and Government inaction

      Economy is struggling … Inflation at 14 month high … Govt doesn’t care about - reducing the fuel prices although crude is at 52W low - Onion pri...

      By SN Mittal
      /
    • INR to USD at 105 within 5 yeara

      INR continues to fall because: there is less demand of INR in the international market (in context of USD/AED). you need to know this fact:- Every time INR depreciates by 4%...

      By Ruchika L Maheshwari
      /
    • Indians are becoming poorer

      Exchange Rate of INR(₹) Against USD($) • November 2004 - ₹45.03 • November 2014 - ₹61.01 • November 2024 - ₹84.07 Value of ₹1 Crore is Not The Same An...

      By Sanjit Jha
      /
    • China vs India

      Some weeks back this circle was discussing China And doing polls on much Chinese Indians were buying China will eat India's manufacturing business in a blip and we won't be able to do a ...

      By Aseem Das
      /
    • Black Money and Real Estate

      What an eye opening survey by LocalCircles on black money in real estate. https://www.l...

      By Mala Sehgal
      /
    • Developing Tourism

      Foreign Tourists in 10 Months of 2024. Thailand: 29.08 Million Vietnam: 14.1 Million India: 4.7 Million (till July) This is one of the major sector for employment a...

      By Shikha Jain
      /
    • By Ruchika L Maheshwari
      /
Share
Enter your email and mobile number and we will send you the instructions

Note - The email can sometime gets delivered to the spam folder, so the instruction will be send to your mobile as well

All My Circles
Invite to
(Maximum 500 email ids allowed.)